Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

More women than men currently live with heart failure (HF) in the United States [(1)][1]; this imbalance is projected to persist over the next decade [(2)][2]. Sex influences biologic drivers, etiologies, background epidemiology, markers of risk, and care quality in HF. To bolster enrollment of